Merck (MRK) Total Non-Current Liabilities (2009 - 2026)

Merck has disclosed Total Non-Current Liabilities across 17 years of filings, most recently posting $75.2 billion for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities rose 25.14% year-over-year to $75.2 billion; the TTM figure through Mar 2026 stood at $75.2 billion (up 25.14% YoY), while the FY2025 annual figure was $76.5 billion, changed N/A from the prior year.
• Total Non-Current Liabilities fell to $75.2 billion in Q1 2026, from $76.5 billion in the prior quarter.
• Over the last five years, Total Non-Current Liabilities for MRK reached as high as $76.5 billion in Q4 2025 and fell as low as $600.0 million in Q1 2022.
• The 5-year median for Total Non-Current Liabilities is $675.0 million (2022), against an average of $24.9 billion.
• Annual changes were most pronounced in 2023 — Total Non-Current Liabilities changed 0.0% — and 2025, when it jumped 7908.93%.
• A 5-year view of Total Non-Current Liabilities shows it stood at $600.0 million in 2022, then advanced by 25.0% to $750.0 million in 2023, then changed by 0.0% to $750.0 million in 2024, then jumped by 10102.13% to $76.5 billion in 2025, then slipped by 1.77% to $75.2 billion in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $75.2 billion, $76.5 billion, and $70.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.